Advancing the future of AFib care
Our pipeline focuses on developing safe, effective therapies to improve atrial fibrillation treatment in both hospital and home settings.
Heart innovation
Transforming atrial fibrillation treatment through science and vision
We aim to move each program through concept, clinical testing, registration, and launch to deliver safe, effective atrial fibrillation therapies.
Product Candidate
Medically Supervised Hospital Cardioversion Program
IV Fixed Dose Combination
Preclinical
Phase 1
Phase 2
Phase 3
Regulatory Approval
Product Candidate
Home Cardioversion Program
Preclinical
Phase 1
Phase 2
Phase 3
Regulatory Approval
Product Candidate
Preclinical
Phase 1
Phase 2
Phase 3
Regulatory Approval
Hospital Inpatient and Outpatient Cardioversion program
IV Fixed Dose Combination
Home Cardioversion Program
Better care, better outcomes
Why our approach stands apart
1
Fast and covenient
Restores normal rhythm in minutes
2
Safe and effective
Minimizes side effects while improving outcomes
3
Lowers health care costs
Reduces hospital stays and enables at-home cardioversion
Contact
Connect with us to learn more
We’d love to hear from you — whether you’re a patient, clinician, partner, or investor, our team is ready to connect.
Contact us
